Education
About Us
Working with TipRanks
Follow Us
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
RESEARCH TOOLSreports
Total Valuation
JCR Pharmaceuticals Co., Ltd. has a market cap or net worth of ¥61.13B. The enterprise value is ¥91.22B.
Market Cap¥61.13B
Enterprise Value¥91.22B
Share Statistics
JCR Pharmaceuticals Co., Ltd. has 129,686,310 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding129,686,310
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
JCR Pharmaceuticals Co., Ltd.’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.11%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)7.11%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee45.90M
Profits Per Employee5.90M
Employee Count934
Asset Turnover0.42
Inventory Turnover0.56
Valuation Ratios
The current PE Ratio of JCR Pharmaceuticals Co., Ltd. is 19.03. JCR Pharmaceuticals Co., Ltd.’s PEG ratio is 0.42.
PE Ratio19.03
PS Ratio0.00
PB Ratio1.87
Price to Fair Value1.87
Price to FCF14.52
Price to Operating Cash Flow11.26
PEG Ratio0.42
Income Statement
In the last 12 months, JCR Pharmaceuticals Co., Ltd. had revenue of 42.87B and earned 5.51B in profits. Earnings per share was 44.13.
Revenue42.87B
Gross Profit31.25B
Operating Income7.53B
Pretax Income7.24B
Net Income5.51B
EBITDA10.53B
Earnings Per Share (EPS)44.13
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
JCR Pharmaceuticals Co., Ltd. pays an annual dividend of ¥20, resulting in a dividend yield of 4.02%
Dividend Per Share¥20
Dividend Yield4.02%
Payout Ratio-540.54%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.05
52-Week Price Change-36.66%
50-Day Moving Average483.68
200-Day Moving Average577.92
Relative Strength Index (RSI)58.01
Average Volume (3m)622.18K
Important Dates
JCR Pharmaceuticals Co., Ltd. upcoming earnings date is May 13, 2025, TBA Not Confirmed.
Last Earnings DateJan 31, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
JCR Pharmaceuticals Co., Ltd. as a current ratio of 1.91, with Debt / Equity ratio of 61.61%
Current Ratio1.91
Quick Ratio1.22
Debt to Market Cap0.22
Net Debt to EBITDA0.43
Interest Coverage Ratio87.58
Taxes
In the past 12 months, JCR Pharmaceuticals Co., Ltd. has paid 1.71B in taxes.
Income Tax1.71B
Effective Tax Rate0.24
Enterprise Valuation
JCR Pharmaceuticals Co., Ltd. EV to EBITDA ratio is 10.39, with an EV/FCF ratio of 15.15.
EV to Sales2.55
EV to EBITDA10.39
EV to Free Cash Flow15.15
EV to Operating Cash Flow11.74
Balance Sheet
JCR Pharmaceuticals Co., Ltd. has ¥15.51B in cash and marketable securities with ¥23.30B in debt, giving a net cash position of ¥16.88B billion.
Cash & Marketable Securities¥15.51B
Total Debt¥23.30B
Net Cash¥16.88B
Net Cash Per Share¥130.15
Tangible Book Value Per Share¥424.54
Margins
Gross margin is 70.26%, with operating margin of 17.57%, and net profit margin of 12.85%.
Gross Margin70.26%
Operating Margin17.57%
Pretax Margin16.90%
Net Profit Margin12.85%
EBITDA Margin24.56%
EBIT Margin17.10%
Analyst Forecast
The average price target for JCR Pharmaceuticals Co., Ltd. is ¥700.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥700.00
Price Target Upside40.85% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-15.31%
EPS Growth Forecast-104.20%